b-(4-溴苯基)戊二酸 | 1141-24-8

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 苯丙酸
• 中文名称: b-(4-溴苯基)戊二酸
• 英文名称: 3-(4-bromo)-phenylglutaric acid
• 英文别名: 3-(4-bromophenyl)pentanedioic acid；3-(4'-Bromphenyl)-glutaric acid；3-(4-Brom-phenyl)-glutarsaeure
• CAS: 1141-24-8
• 化学式: C₁₁H₁₁BrO₄
• 分子量: 287.11
• InChiKey: ZSYRDSTUBZGDKI-UHFFFAOYSA-N

物化性质

• 熔点：
  177-178 °C
• 沸点：
  424.0±30.0 °C(Predicted)
• 密度：
  1.613±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  16
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  74.6
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2917399090

反应信息

• 作为反应物：
  描述：

  b-(4-溴苯基)戊二酸 在 吡啶 、 氯化亚砜 作用下， 以 苯 为溶剂， 生成
  参考文献：
  名称：

  Investigation of a Photochromic Diarylethene with Electron-acceptor Attached

  摘要：

  In this contribution, an electron acceptor attached diarylethene derivative was synthesized and fully characterized. The photochromic behavior was investigated in THF. Under exposure of UV and visible light cycles, the solution color can be switched between colorless and yellow smoothly. Fatigue resistance measurements could be repeated 50times with an acceptable degradation. Due to the electron acceptor attached to the framework of diarylethene, the photo- and thermal-stability were enhanced both. A full-photo mode switch can be established based on the well-defined states by external excitation. The molecular structures of ring-open and ring-closed form were optimized by Dmol(3). The distance between photocyclizing atoms in aptiparallel conformation meets the requirement for photochromic reaction. And the calculated absorption wavelengths were also in agreement with the experimental values.

  DOI：

  10.1080/15421406.2015.1096440
• 作为产物：
  描述：

  3-苯基戊二酸 在 溴 作用下， 生成 b-(4-溴苯基)戊二酸
  参考文献：
  名称：

  Notes - Bromination of β-Phenylglutaric Acid

  摘要：

  DOI：

  10.1021/jo01112a614
• 作为试剂：
  描述：

  sodium hydroxide 、 盐酸 、 b-(4-溴苯基)戊二酸 在 ice 、 水 、 b-(4-溴苯基)戊二酸 、 petrol ether 、 乙酰氯 作用下， 以 乙酰氯 为溶剂， 反应 3.0h， 以to give 3-(4-bromophenyl)-glutaric anhydride (12.3 g) as colourless crystals的产率得到3-(4-bromo)-phenylglutaric acid anhydride
  参考文献：
  名称：

  ALLOSTERIC PROTEIN KINASE MODULATORS

  摘要：

  该发明提供了特定的小分子化合物，可以对AGC蛋白激酶和Aurora蛋白激酶家族的活性进行变构调节或调节蛋白质-蛋白质相互作用，以及制备它们的方法，包括它们的制药组合物，以及它们用于制备治疗与AGC蛋白激酶或Aurora家族蛋白激酶异常活性相关的疾病的药物的用途。

  公开号：

  US20120046307A1

文献信息

• [EN] 2, 3, 6-TRISUBSTITUTED-4-PYRIMIDONE DERIVATIVES<br/>[FR] DERIVES DE 2,3,6-TRISUBSTITUE 4-PYRIMIDONE
  申请人：MITSUBISHI PHARMA CORP

  公开号：WO2004085408A1

  公开（公告）日：2004-10-07

  A pyrimidone derivative having tau protein kinase 1 inhibitory activity which is represented by formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof; useful for prventive and/or therapeutic treatment of diseass such as neurodegenerative diseases (e.g. Alzheimer disease); wherein Q represents CH or nitrogen atom; R represents a C1-C12 alkyl group; the ring of Formula (I): represents piperazine ring or piperidine ring; each X independently represents a C1-C8 alkyl group, an optionally partially hydrogenated C6-C10 aryl ring, an indan ring or the like; m represents an integer of 1 to 3; each Y independently represents a halogen atom, a hydroxy group, a cyano group, a C1-C6 alkyl group or the like; n represents an integer of 0 to 8; when X and Y or two Y groups are attached on the same carbon atom, they may combine to each other to form a C2-C6 alkylene group.

  一种具有tau蛋白激酶1抑制活性的嘧啶酮衍生物，其由化学式（I）或其盐、溶剂合物或水合物表示；用于预防和/或治疗神经退行性疾病（例如阿尔茨海默病）；其中Q代表CH或氮原子；R代表C1-C12烷基基团；化学式（I）的环：代表哌嗪环或哌啶环；每个X独立地代表C1-C8烷基基团、可选择性部分氢化的C6-C10芳环、茚环或类似物；m代表1到3的整数；每个Y独立地代表卤素原子、羟基、氰基、C1-C6烷基基团或类似物；n代表0到8的整数；当X和Y或两个Y基团连接在同一碳原子上时，它们可以结合形成C2-C6烷基基团。
• [EN] ALLOSTERIC PROTEIN KINASE MODULATORS<br/>[FR] MODULATEURS DE PROTÉINE KINASE ALLOSTÉRIQUE
  申请人：UNIV SAARLAND

  公开号：WO2010043711A1

  公开（公告）日：2010-04-22

  The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.

  该发明提供特定的小分子化合物，这些化合物能够变构调节AGC蛋白激酶的活性或调节Aurora家族蛋白激酶的蛋白-蛋白相互作用，提供这些化合物的制备方法，包含这些化合物的药物组合物，以及它们用于制备治疗和预防与AGC蛋白激酶或Aurora家族蛋白激酶异常活动相关疾病的药物的应用。
• Solid-Phase Synthesis of a Nonpeptide RGD Mimetic Library:  New Selective αvβ3 Integrin Antagonists
  作者：Gábor A. G. Sulyok、Christoph Gibson、Simon L. Goodman、Günter Hölzemann、Matthias Wiesner、Horst Kessler

  DOI：10.1021/jm0004953

  日期：2001.6.1

  solid-phase synthesis of a low molecular weight RGD mimetic library is described. Activities of the compounds in inhibiting the interaction of ligands, vitronectin and fibrinogen, with isolated immobilized integrins alphavbeta3 and alphaIIbbeta3 were determined in a screening assay. Highly active and selective nonpeptide alphavbeta3 integrin antagonists with regard to orally bioavailability were developed

  描述了低分子量RGD模拟物库的固相合成。在筛选分析中确定了化合物在抑制配体，玻连蛋白和纤维蛋白原与分离的固定化整合素αvbeta3和αIIbbeta3相互作用中的活性。基于含氮杂甘氨酸的先导化合物1，开发了具有高活性和选择性的非肽αvbeta3整联蛋白拮抗剂，具有口服生物利用度。一个重要的变化是芳香残基取代了天冬酰胺1。此外，已经引入了不同的胍模拟物以改善药代动力学特征。一组RGD模拟物中的亚甲基部分与β-氨基酸NH的交换产生了代表一种新型拟肽方法的杜鹃花类似物化合物，
• [EN] SUBSTITUTED INDANONE COMPOUNDS AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS<br/>[FR] COMPOSÉS INDANONE SUBSTITUÉS UTILES EN TANT QUE MODULATEURS DE GPR119 POUR LE TRAITEMENT DU DIABÈTE, DE L'OBÉSITÉ, DE LA DYSLIPIDÉMIE ET DE TROUBLES ASSOCIÉS
  申请人：SANOFI SA

  公开号：WO2015150563A1

  公开（公告）日：2015-10-08

  The present invention relates to indanone compounds. The indanone compounds are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of indanone compounds as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.

  本发明涉及茚酮化合物。这些茚酮化合物是GPR119调节剂，对于预防和/或治疗糖尿病、肥胖、血脂异常及相关疾病具有用处。此外，本发明还涉及将茚酮化合物用作药物中的活性成分，以及包含它们的药物组合物。
• From Diols to Lactones under Aerobic Conditions using a Laccase/TEMPO Catalytic System in Aqueous Medium
  作者：Alba Díaz-Rodríguez、Iván Lavandera、Seda Kanbak-Aksu、Roger A. Sheldon、Vicente Gotor、Vicente Gotor-Fernández

  DOI：10.1002/adsc.201200892

  日期：2012.12.14

  An efficient catalytic system to oxidize quantitatively aliphatic diols using Trametes versicolor laccase and TEMPO has been developed in aqueous medium. Oxidations have occurred in a non-stereoselective fashion but with complete regio- and/or monoselectivity, obtaining lactones with excellent purity after simple extraction. This catalytic system has been demonstrated to be scalable, compatible with

  在水性介质中，已经开发出一种有效的催化系统，该系统可以使用Trametes versicolor laccase和TEMPO氧化定量氧化脂肪族二醇。氧化以非立体选择性的方式发生，但是具有完全的区域选择性和/或单选择性，在简单提取后获得具有优异纯度的内酯。该催化系统已被证明具有可扩展性，与多种功能的存在兼容，并且还允许使用漆酶交联的酶聚集体（CLEA）制备成功地回收酶。